Revolution Medicines Inc (RVMD)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -462.824 | -52.59 | -31.654 | -28.017 | -28.664 | -32.093 | -30.37 |
Return on Equity (%) | 103.047 | 55.433 | 47.435 | -68.536 | -34.735 | -38.626 | -34.751 |
Return on Invested Capital (%) | -1500.916 | -55.759 | -43.162 | -35.193 | -34.832 | -40.234 | -38.971 |
Operating Margin (%) | N/A | -206.66 | -103.777 | -252.33 | -636.54 | -704.141 | -3796.097 |
Net Profit Margin (%) | N/A | -242.103 | -123.703 | -256.795 | -636.58 | -702.954 | -3768.282 |
Book Value Per Share | 0.348 | 1.215 | 23.06 | 5.993 | 7.123 | 6.767 | 16.007 |
Earnings Per Share | -2.682 | -3.126 | -18.804 | -1.657 | -2.523 | -2.751 | -3.983 |
Cash Per Share | 0.698 | 4.456 | 5.06 | 1.566 | 1.463 | 1.785 | 6.354 |
Working Capital Per Share | 0.142 | 3.515 | 27.621 | 6.11 | 7.141 | 6.616 | 15.839 |
Operating Profit Per Share | N/A | 1.291 | 15.201 | 0.645 | 0.396 | 0.391 | 0.106 |
EBIT Per Share | -2.392 | -2.676 | -15.807 | -1.63 | -2.523 | -2.755 | -4.015 |
EBITDA Per Share | -2.392 | -2.676 | -15.807 | -1.63 | -2.523 | -2.755 | -4.015 |
Free Cash Flow Per Share | -2.652 | -3.143 | -19.033 | -1.669 | -2.492 | -2.687 | -3.968 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 13.01M | 15.62M | 3.29M | 66.6M | 74.14M | 90.41M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 90.41M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -970.887 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -970.887 | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 9.27B |
Price to Earnings Ratio | -0.16 |
Price to Sales Ratio | 6.1 |
Price to Cash Ratio | 0.1 |
Price to Book Ratio | 0.04 |
Dividend Yield | - |
Shares Outstanding | 168.22M |
Average Volume (1 week) | 1.47M |
Average Volume (1 Month) | 1.67M |
52 Week Change | 154.17% |
52 Week High | 62.40 |
52 Week Low | 20.51 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.